Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
---|
03/14/2002 | WO2002020014A1 Incompetitive inhibitors of helicase primase |
03/14/2002 | WO2001085760A8 Thrombin inhibitors |
03/14/2002 | WO2001072290A3 Method for the improvement of islet signaling in diabetes mellitus and for its prevention |
03/14/2002 | US20020032346 Production of mixed acid anhydride and amide compound |
03/14/2002 | US20020032227 Oxime derivative and bactericide containing the same as active ingredient |
03/14/2002 | US20020032225 Treatment of inflammation, inflammatory and immunological diseases, insulin resistance, hyperlipidemia, coronary artery disease, cancer and multiple sclerosis. |
03/14/2002 | US20020032222 Azolidines as beta-3 adrenergic receptor agonists |
03/14/2002 | US20020032189 Amine compounds, their production and use |
03/14/2002 | US20020032186 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
03/14/2002 | CA2421506A1 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents |
03/13/2002 | EP1186606A1 Epothilone derivatives, their preparation and utilization |
03/13/2002 | EP1186594A1 N-alkoxyalkyl-n,n-dialkylamine derivatives or salts thereof, and remedies for nerve degeneration diseases containing the same |
03/13/2002 | EP1186588A1 6-hydroxy-2-naphthylcarbinol and process for the preparation thereof |
03/13/2002 | EP1186318A2 Combination, for treating depression and anxiety, containing a 5HT1d receptor antagonist and aCNS penetrant NK-1 receptor antagonist |
03/13/2002 | EP1185521A1 Substituted 1-aza-2-imino-heterocycles and their use as activators of nicotinic acetylcholine receptors |
03/13/2002 | EP1185520A1 Method for the production of thiazolidin |
03/13/2002 | EP1185261A1 Il-8 receptor antagonists |
03/13/2002 | EP0858452B1 Thiazole derivative as protein kinase c inhibitors |
03/13/2002 | EP0802910B1 Estrogen agonists/antagonists |
03/13/2002 | CN1340049A 4-heterocyclylsulfonamide)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl-or-pyridylpyrimidines as endothelin receptor antagonists |
03/13/2002 | CN1080720C 噻唑衍生物 Thiazole derivatives |
03/12/2002 | US6355806 Regulators of cell proliferation and differentiation, agents for treating skin-related diseases |
03/12/2002 | US6355805 β3-adrenergic receptor agonists |
03/12/2002 | US6355673 Substituted diaminocarboxylic acids |
03/12/2002 | US6355672 Bone disorders; central nervous system disorders |
03/12/2002 | US6355662 Peptide and nonpeptides autoimmune diseases, antiinflammatory agents |
03/12/2002 | US6355441 Benzothiazole dioxetanes |
03/07/2002 | WO2002018365A1 N-heteroarylmethyl-p-phenylendiamine derivatives and compounds containing oxidation colouring agents |
03/07/2002 | WO2002018333A1 Phenoxybenzylamine derivatives as selective serotonin re-uptake inhibitors |
03/07/2002 | WO2002018321A2 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors |
03/07/2002 | WO2002017915A1 Benzylidene thiazolidinediones and their use as antimycotic agents |
03/07/2002 | WO2002017712A2 Disubstituted benzenes as insecticides |
03/07/2002 | WO2001093802A3 Use of riluzole or its salts for preventing and treating adrenoleukodystrophy |
03/07/2002 | WO2001068645A3 N-cyanomethylcarboxamides and their use as protease inhibitors |
03/07/2002 | US20020028975 Process for preparing retiferol derivatives |
03/07/2002 | US20020028950 Guanidinylamino heterocycle compunds useful as alpha-2 adrenoceptor agonists |
03/07/2002 | US20020028946 Process for the preparation of heteroaryl-phenylalanines |
03/07/2002 | US20020028818 2-nitrostyryl-1-(naphthylmethyl)sulfone for example |
03/07/2002 | US20020028809 Heterocyclic compounds having effect of activating a4beta2 nicotinic acetylcholine receptors |
03/07/2002 | US20020028806 As a pour-on or spot-on on formulation for controlling parasites such as fleas in warm blooded animals; such as 2,2-dimethylbutyric acid, (1-((6-chloro-pyridin-3-ylmethyl)-ethyl-amino)-2-nitrovinyl)-methyl -carbamoyloxy)-methyl ester |
03/07/2002 | CA2420969A1 Phenoxybenzylamine derivatives as selective serotonin re-uptake inhibitors |
03/06/2002 | EP1183247A1 Polycyclic thiazole systems and their utilization as anorectics |
03/06/2002 | EP1183245A1 Selective npy (y5) antagonists |
03/06/2002 | EP1183237A1 Novel antioxidants, preparation methods and uses |
03/06/2002 | EP1183233A2 Bradykinin receptor antagonists |
03/06/2002 | EP1183229A1 Glucagon antagonists/inverse agonists |
03/06/2002 | EP1183019A2 Ace-2 inhibiting compounds and methods of use thereof |
03/06/2002 | CN1338452A Substituted phenylamine derivatives |
03/06/2002 | CN1080257C Guanidine derivatives |
03/06/2002 | CA2356797A1 Combination treatment for depression and anxiety |
03/05/2002 | US6353111 Which increase insulin secretion in the treatment of type ii diabetes; 2,3-di-substituted trans olefinic n-heteroaromatic or urido propionamides: the substitution at the 2-position being a substituted phenyl group and at the 3-position a |
03/05/2002 | US6353011 Drugs for endocrines and cardiovascular disorders |
03/05/2002 | US6352993 Pyrimidine derivatives and processes for the preparation thereof |
03/05/2002 | US6352987 Anorectic and antidiabetic agents |
03/05/2002 | CA2206122C Arylacrylamide derivatives |
02/28/2002 | WO2002016335A2 Catalytic process for the preparation of thiazole derivatives |
02/28/2002 | WO2002016334A1 Continuous process for the preparation of pesticidal chlorothiazoles |
02/28/2002 | WO2002016333A2 Thioflavin derivatives and their use in diagnosis and theraphy of alzheimer's disease |
02/28/2002 | WO2002016327A1 Benzimidazoles and analogues and their use as neutrophil inhibitors |
02/28/2002 | WO2002016319A1 Novel thiourea compounds and the pharmaceutical compositions containing the same |
02/28/2002 | WO2002016318A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
02/28/2002 | WO2002016316A1 10-ARYL-11-HBENZO [b]FLUORENE DERIVATIVES AND ANALOGS FOR MEDICINAL USE |
02/28/2002 | WO2001076390A3 Flavouring a foodstuff with compounds containing a sulfur atom linked to two specific atoms or groups |
02/28/2002 | US20020026060 RAR selective retinoid agonists |
02/28/2002 | US20020025976 Thiazole compounds and pharmaceutical compositions for inhibiting protein kinases and methods for their use |
02/28/2002 | US20020025975 Antidiabetic agents; antiinflammatory agents |
02/28/2002 | US20020025910 3-heterocycly1 - substituted benzoyl derivatives |
02/28/2002 | CA2420289A1 10-aryl-11-hbenzo [b]fluorene derivatives and analogs for medicinal use |
02/28/2002 | CA2417507A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
02/27/2002 | EP1182199A1 Process for preparing amic acid esters |
02/27/2002 | EP1181283A1 Diaminothiazoles and their use for inhibiting protein kinases |
02/27/2002 | EP1181267A1 Halogen compounds |
02/27/2002 | EP0971907B1 Method for producing 1,3-di-substituted 2-nitroguanidines |
02/27/2002 | CN1337955A Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents |
02/27/2002 | CN1337941A Amide derivatives |
02/27/2002 | CN1337932A Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treamtent of respiratory diseases |
02/27/2002 | CN1079792C 酶抑制剂 Inhibitors |
02/26/2002 | US6350892 Trifluoromethyl ketone analogs as selective cPLA2 inhibitors |
02/26/2002 | US6350878 Intermediates for the synthesis of epothilones and methods for their preparation |
02/26/2002 | US6350767 Growth hormone release stimulant |
02/26/2002 | CA2206776C N-sulfonylindoline derivatives carrying an amide functional group, their preparation and the pharmaceutical compositions in which they are present |
02/26/2002 | CA2128119C Benzospiroalkene derivatives, process for their preparation and pharmaceutical compositions containing them |
02/21/2002 | WO2002014312A1 Tetrazolyl-phenyl acetamide glucokinase activators |
02/21/2002 | WO2002014294A2 Heterocyclic sulfonamide derivatives and their use for potentiating glutamate receptor function |
02/21/2002 | WO2002014291A1 PPARδ ACTIVATORS |
02/21/2002 | WO2002014275A2 Heterocyclic sulfonamide derivatives and their use for potentiating glutamate receptor function |
02/21/2002 | WO2002014261A2 4-substituted d-glutamic acid derivatives for use as antibiotic |
02/21/2002 | WO2002014259A1 Calcium receptor antagonists |
02/21/2002 | WO2002013611A1 2-phenyliminothiazolines, their preparation method and anti-rice blast agent containing the same |
02/21/2002 | WO2001081328A3 Thiazolidinedione analogues and their use for the treatment of diabetes |
02/21/2002 | WO2000054729A8 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
02/21/2002 | US20020022631 Use of 2-aminothiazoline derivatives as inhibitors of inducible no-synthase |
02/21/2002 | US20020022622 Administering effective amount of oxalzole, thiazole or imidazole derivatives to cure diseases associated with protein aging |
02/21/2002 | DE10039998A1 Neue substituierte Diareno-azepin-Derivate als Integrin Liganden New substituted Diareno-azepine derivatives as integrin ligands |
02/21/2002 | DE10039265A1 New 2-acylamino-5-aminosulfonyl-1,3-thiazole derivatives, useful as antiviral agents, especially for treatment or prophylaxis of herpes simplex virus infections |
02/20/2002 | EP1180519A1 Hydrochloride of fused-heterocycle compound |
02/20/2002 | EP1180512A1 Fungicidal phenylimine derivatives |
02/20/2002 | EP1180098A1 New compounds |
02/20/2002 | CN1336930A Bridged heterocyclic derivatives |
02/20/2002 | CN1336921A Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4 |